Browsing Category
Pharma Industry News
4764 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Lupin Limited bags FDA approval for Generic Ganirelix Acetate Injection
Lupin Limited, a global pharma major, has announced its receipt of approval from the United States Food and…
Takeda’s TAKHZYRO approved by EC for pediatric hereditary angioedema
Takeda has announced a significant advancement in the treatment of Hereditary Angioedema (HAE), with the European Commission’s approval…
Lilly announces $2.5bn high-tech manufacturing site in Alzey, Germany
Eli Lilly and Company (NYSE: LLY) unveiled its plan to build a $2.5 billion state-of-the-art manufacturing site in…
Ajinomoto to acquire Forge Biologics for $620m to enhance genetic medicine capabilities
Ajinomoto Co., Inc., a prominent player in the biotechnology industry, has entered into a definitive agreement to acquire…
Argenica Therapeutics’ ARG-007 gets FDA orphan drug status in hypoxic ischaemic encephalopathy
Argenica Therapeutics Limited (ASX: AGN), a leading biotechnology company specializing in developing therapeutics for brain injuries and neurological…
AstraZeneca’s PACIFIC-2 Phase 3 trial for Imfinzi in NSCLC falls short of primary endpoint
In the latest development in oncology research, AstraZeneca’s PACIFIC-2 Phase III trial, involving Imfinzi (durvalumab) concurrently administered with…
Novartis’ remibrutinib shows promising results in Phase III studies for chronic spontaneous urticaria
Novartis has revealed encouraging data from the Phase III REMIX-1 and REMIX-2 studies. The studies focused on remibrutinib,…
AstraZeneca reports steady growth in 9M and Q3 2023 with core EPS increase
AstraZeneca has announced its financial results for the nine months (9M) and third quarter (Q3) of 2023, displaying…
Takeda gets ADZYNMA FDA approval for cTTP treatment: A new era in rare disease therapy
Takeda has achieved a monumental milestone in rare disease therapy with the U.S. Food and Drug Administration’s approval…
Torrent Pharmaceuticals to co-market Saroglitazar Mg with Zydus for liver health
Torrent Pharmaceuticals Limited and Zydus Lifesciences Limited announced a significant licensing and supply agreement to co-market Saroglitazar Mg,…